We are live on ! Find out more
MTEM

Molecular Templates, Inc.

Delisted

MTEM was delisted on the 24th of December, 2024.

87 hedge funds and large institutions have $143M invested in Molecular Templates, Inc. in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 24

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

1% more funds holding

Funds holding: 8687 (+1)

4% less capital invested

Capital invested by funds: $149M → $143M (-$5.22M)

16% less call options, than puts

Call options by funds: $385K | Put options by funds: $460K

Holders
87
Holders Change
+1
Holders Change %
+1.16%
% of All Funds
2.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
29
Reduced
24
Closed
16
Calls
$385K
Puts
$460K
Net Calls
-$75K
Net Calls Change
-$25K
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
1
JP Morgan Chase
New York
$14.7M +$27.9K +37 +0.2%
Federated Hermes
2
Federated Hermes
Pennsylvania
$14.2M -$1.4M -1,860 -9%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$11.9M -$10.4M -13,765 -47%
BIT
4
BlackRock Institutional Trust
California
$9.36M +$2.31M +3,068 +34%
BBA
5
Baker Bros. Advisors
New York
$8.65M
UBS AM
6
UBS AM
Illinois
$8.48M
Franklin Resources
7
Franklin Resources
California
$7.85M +$1.37M +1,813 +22%
Vanguard Group
8
Vanguard Group
Pennsylvania
$6.12M +$76.2K +101 +1%
BFA
9
BlackRock Fund Advisors
California
$6.02M -$267K -354 -4%
State Street
10
State Street
Massachusetts
$5.78M +$655K +869 +13%
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$4.56M -$485K -643 -10%
Millennium Management
12
Millennium Management
New York
$3.26M +$719K +953 +29%
Northern Trust
13
Northern Trust
Illinois
$3.14M +$147K +195 +5%
Charles Schwab
14
Charles Schwab
California
$3.05M +$358K +475 +14%
Axa
15
Axa
France
$2.71M +$1.5M +1,988 +130%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$2.32M +$112K +149 +5%
Morgan Stanley
17
Morgan Stanley
New York
$2.03M +$1.83M +2,430 +1,168%
BA
18
BlackRock Advisors
Delaware
$1.92M +$1.7M +2,260 +983%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$1.61M +$793K +1,051 +101%
Deutsche Bank
20
Deutsche Bank
Germany
$1.47M -$260K -345 -15%
TCIM
21
TIAA CREF Investment Management
New York
$1.47M -$210K -279 -13%
DCM
22
DAFNA Capital Management
California
$1.31M +$1.28M +1,700 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$1.23M -$3.02K -4 -0.3%
RPAM
24
Rhenman & Partners Asset Management
Sweden
$1.17M +$1.14M +1,515 New
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$1.14M +$921K +1,221 +471%

MTEM Hedge Fund Activity: Q4 2013 in Review

87 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q4 2013, worth a combined $143M — down 3.5% from $149M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new MTEM positions and 16 closed out — a net gain of 2 holders — while 29 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $2.31M. The largest seller was Fidelity Investments, cutting an estimated $10.4M.

  • 87 institutional investors held Molecular Templates, Inc. (MTEM) as of Q4 2013, up from 86 in Q3 2013.
  • Funds reported $143M of Molecular Templates, Inc. stock for Q4 2013, down 3.5% quarter-over-quarter.
  • 18 funds opened new Molecular Templates, Inc. positions in Q4 2013 and 16 closed out, a net change of +2 holders.
  • The largest Molecular Templates, Inc. buyer in Q4 2013 was BlackRock Institutional Trust, an estimated $2.31M added.
  • The largest Molecular Templates, Inc. seller in Q4 2013 was Fidelity Investments, an estimated $10.4M sold.

Based on aggregated 13F filings for Q4 2013.